Psychiatric Symptoms, Psychosocial Factors, and Life Satisfaction Among Persons With Serious Mental Illness

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Jennifer Sánchez ◽  
John S. Wadsworth ◽  
Michael P. Frain ◽  
Emre Umucu ◽  
Fong Chan
2016 ◽  
Vol 22 (2) ◽  
pp. 135-146 ◽  
Author(s):  
Jennifer Sánchez ◽  
Joseph S. Pfaller ◽  
Kanako Iwanaga ◽  
Fong Chan ◽  
Connie Sung ◽  
...  

The objectives of this study were (1) to evaluate the measurement structure of thePerceived Empathic and Social Self-Efficacy Scaleamongst 194 individuals with serious mental illness (SMI) and (2) to establish construct validity for thePerceived Empathic and Social Self-Efficacy Scale. Confirmatory factor analysis yielded a two-factor measurement structure of thePerceived Empathic and Social Self-Efficacy Scale, which was positively associated with insight, social support, and life satisfaction. ThePerceived Empathic and Social Self-Efficacy Scaleis a useful measure to assess social skills amongst individuals with SMI in rehabilitation counselling.


2019 ◽  
Author(s):  
Travis T. Mallard ◽  
Richard K. Linnér ◽  
Andrew D. Grotzinger ◽  
Sandra Sanchez-Roige ◽  
Jakob Seidlitz ◽  
...  

AbstractUnderstanding which biological pathways are specific versus general across diagnostic categories and levels of symptom severity is critical to improving nosology and treatment of psychopathology. Here, we combine transdiagnostic and dimensional approaches to genetic discovery for the first time, conducting a novel multivariate genome-wide association study (GWAS) of eight psychiatric symptoms and disorders broadly related to mood disturbance and psychosis. We identify two transdiagnostic genetic liabilities that distinguish between common forms of mood disturbance (major depressive disorder, bipolar II, and self-reported symptoms of depression, mania, and psychosis) versus rarer forms of serious mental illness (bipolar I, schizoaffective disorder, and schizophrenia). Biological annotation revealed divergent genetic architectures that differentially implicated prenatal neurodevelopment and neuronal function and regulation. These findings inform psychiatric nosology and biological models of psychopathology, as they suggest the severity of mood and psychotic symptoms present in serious mental illness may reflect a difference in kind, rather than merely in degree.


1993 ◽  
Vol 17 (3) ◽  
pp. 140-141 ◽  
Author(s):  
Joy Abbati ◽  
Greg Oles

It has been claimed (Abbati et al, 1987) that patients benefit from continuity of professional involvement sustained over a long period. Schizophrenia sufferers in particular find it harder than non-sufferers to articulate their difficulties and concerns, and may adjust poorly to change, only building up trust in professionals over an extended period. In their turn, professionals need time to get to know such individuals and to recognise ‘early signs’ (Birchwood et al, 1989) of possible relapse. Management of potential decompensation involves a knowledge of how the individual has responded to changes in medication in the past and what psychosocial factors may be relevant. Working with such patients refines the clinician's skills in interacting with them, obtaining their compliance with a particular regime, and pre-empting potential problems. Without this background of knowledge and experience, the management of sufferers may be crude with adverse results for the patient.


2020 ◽  
pp. 1-6
Author(s):  
Michael Heinbach ◽  
Astrid Block ◽  
Erin Hubbard ◽  
Janine Cataldo ◽  
Bruce Cooper ◽  
...  

2019 ◽  
Vol 21 (Supplement_1) ◽  
pp. S38-S45 ◽  
Author(s):  
Jennifer W Tidey ◽  
Suzanne M Colby ◽  
Rachel L Denlinger-Apte ◽  
Christine Goodwin ◽  
Patricia A Cioe ◽  
...  

Abstract Introduction The US Food and Drug Administration is considering implementing a reduced-nicotine standard for cigarettes. Given the high rate of smoking among people with serious mental illness (SMI), it is important to examine the responses of these smokers to very low nicotine content (VLNC) cigarettes. Methods This trial compared the effects of VLNC (0.4 mg nicotine/g tobacco) and normal nicotine content cigarettes (15.8 mg/g) over a 6-week period in non-treatment-seeking smokers with schizophrenia, schizoaffective disorder, or bipolar disorder (n = 58). Linear regression was used to examine the effects of cigarette condition on cigarettes per day, subjective responses, nicotine and tobacco toxicant exposure, craving, withdrawal symptoms, and psychiatric symptoms. Results At week 6, participants in the VLNC condition smoked fewer cigarettes per day, had lower breath carbon monoxide levels, lower craving scores, and rated their study cigarettes lower in satisfaction, reward, enjoyment, and craving reduction than those in the normal nicotine content condition (ps < .05). Week 6 psychiatric and extrapyramidal symptoms did not differ by condition, except for scores on a measure of parkinsonism, which were lower in the VLNC condition (p < .05). There were no differences across conditions on total nicotine exposure, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, withdrawal symptoms, or responses to abstinence. Conclusions These results suggest that a reduced-nicotine standard for cigarettes would reduce smoking among smokers with SMI. However, the lack of effect on total nicotine exposure indicates VLNC noncompliance, suggesting that smokers with SMI may respond to a reduced-nicotine standard by substituting alternative forms of nicotine. Implications Results from this trial suggest that a reduced-nicotine standard for cigarettes would reduce smoking rates and smoke exposure in smokers with SMI, without increasing psychiatric symptoms. However, noncompliance with VLNC cigarettes was observed, suggesting that these smokers might respond to a reduced-nicotine standard by substituting alternative forms of nicotine.


2021 ◽  
pp. 79-95
Author(s):  
Marc J. Weintraub ◽  
Jamie Zinberg

Youths with or at high risk for serious mental illness (SMI; i.e., psychotic or bipolar disorders) have heterogeneous psychiatric symptoms, including significant overlap with more common depressive and anxiety disorders. There are also heterogeneous illness trajectories, as some youth go on to develop chronic and debilitating SMIs while a large proportion have symptoms that remit or remain relatively milder. This chapter presents the rationale for using the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) as a first-line, transdiagnostic, cognitive-behavioral treatment for youth with early SMI symptoms. This treatment is delivered in a group format including parents in an effort to reduce stigma, increase social support, and improve skill acquisition. Preliminary feasibility and efficacy data are presented as well as a case vignette. Recommendations are offered on how to deliver this treatment and troubleshoot common difficulties.


2020 ◽  
Author(s):  
Maji Hailemariam ◽  
Lauren M Weinstock ◽  
Jennifer E. Johnson

Abstract Background: Serious mental illness (SMI) is a prevalent public health problem affecting 25% of individuals in jail. Re-entry to the community following incarceration is a vulnerable time for justice-involved individuals with SMI. SMI requires prompt and ongoing access to mental health and other healthcare services. Methods: The study will: 1) develop a Mentoring And Peer Support (MAPS) intervention for post-release mental health and other service connection among jailed individuals with SMI, and 2) pilot-test the MAPS intervention to determine the feasibility and acceptability of the MAPS intervention. The primary outcomes will be to evaluate the feasibility and acceptability of the proposed recruitment methods and research design, of the intervention training methods, of delivering the enhanced peer-navigator and control interventions. Study samples include (focus groups, open trial), and a randomized pilot trial in a sample of 40 individuals with SMI re-entering the community after jail release. Secondary outcomes will include post-release enrollment in mental health, medical care, and substance use services. We will also evaluate reduction in psychiatric symptoms, improvements in functioning, adherence to psychiatric medications, fewer substance using days, fewer hospitalizations and suicide attempts, nights unstably housed, and time until rearrest. Discussion: This pilot study will evaluate the feasibility and acceptability of a peer navigation intervention for individuals with serious mental illness leaving jails. The study will serve as a formative work for a larger randomized controlled trial assessing the effectiveness of peer navigator intervention for (include the primary outcome) in this population.


2020 ◽  
Vol 43 (3) ◽  
pp. 205-213
Author(s):  
Veronica Pinho ◽  
Karen McKinnon ◽  
Francine Cournos ◽  
Andrea Norcini Pala ◽  
Maria Cecilia Zea ◽  
...  

2020 ◽  
Author(s):  
Maji Hailemariam ◽  
Lauren M Weinstock ◽  
Jennifer E. Johnson

Abstract Background: Serious mental illness (SMI) is a prevalent public health problem affecting 25% of individuals in jail. Re-entry to the community following incarceration is a vulnerable time for justice-involved individuals with SMI. SMI requires prompt and ongoing access to mental health and other healthcare services.Methods: The study will: 1) develop a Mentoring And Peer Support (MAPS) intervention for post-release mental health and other service connection among jailed individuals with SMI, and 2) pilot-test the MAPS intervention to determine the feasibility and acceptability of the MAPS intervention. The primary outcomes will be to evaluate the feasibility and acceptability of the proposed recruitment methods and research design, of the intervention training methods, of delivering the enhanced peer-navigator and control interventions. Study samples include (focus groups, open trial), and a randomized pilot trial in a sample of 40 individuals with SMI re-entering the community after jail release. Secondary outcomes will include post-release enrollment in mental health, medical care, and substance use services. We will also evaluate reduction in psychiatric symptoms, improvements in functioning, adherence to psychiatric medications, fewer substance using days, fewer hospitalizations and suicide attempts, nights unstably housed, and time until rearrest.Discussion: This pilot study will evaluate the feasibility and acceptability of a peer navigation intervention for individuals with serious mental illness leaving jails. The study will serve as a formative work for a larger randomized controlled trial assessing the effectiveness of peer navigator intervention for (include the primary outcome) in this population.


2019 ◽  
Vol 12 ◽  
pp. 117863291983762
Author(s):  
Evelyn T Chang ◽  
Merlyn Vinzon ◽  
Amy N Cohen ◽  
Alexander S Young

People with serious mental illness have substantially worse health outcomes than people without mental illness. These patients use primary care less often and fail to receive needed preventive and chronic care. While a variety of care models have been implemented with the goal of improving care for these patients, few have been found to be effective. Young et al describes a specialty patient-centered medical home for patients with serious mental illness. In this model, the primary care provider manages the medical and mental health conditions of patients with stable psychiatric symptoms with assistance from a registered nurse and a consulting psychiatrist. The goal of this integrated model is to engage patients in preventive care by building a relationship with them in primary care and understanding both their medical and psychiatric needs. While this model may improve care and increase patient satisfaction, implementing this type of model may be challenging.


Sign in / Sign up

Export Citation Format

Share Document